Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer

Scale Transition ◽

Poor Outcome ◽

613P Chromosomal instability (CIN) biomarker in circulating tumor cells (CTC) may predict for therapy resistance in metastatic castration-resistant prostate cancer (mCRPC)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1126 ◽

2021 ◽

Vol 32 ◽

pp. S653

Author(s):

N.M. Keegan ◽

J. Schonhoft ◽

E. Barnett ◽

E.D. Cohn ◽

J.L. Zhao ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Chromosomal Instability ◽

Therapy Resistance ◽

Synaptophysin expression on circulating tumor cells in patients with castration resistant prostate cancer undergoing treatment with abiraterone acetate or enzalutamide

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2017.12.006 ◽

2018 ◽

Vol 36 (4) ◽

pp. 162.e1-162.e6 ◽

Cited By ~ 8

Author(s):

Sumanta K. Pal ◽

Miaoling He ◽

Lin Chen ◽

Lixin Yang ◽

Raju Pillai ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Abiraterone Acetate ◽

Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving 177Lu-PSMA-617 Radioligand Therapy

Theranostics ◽

10.7150/thno.44556 ◽

2020 ◽

Vol 10 (17) ◽

pp. 7645-7655

Author(s):

Katharina Kessel ◽

Robert Seifert ◽

Matthias Weckesser ◽

Wolfgang Roll ◽

Verena Humberg ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Molecular Analysis ◽

Radioligand Therapy ◽

Clinical Utility of the Nuclear-localized AR-V7 Biomarker in Circulating Tumor Cells in Improving Physician Treatment Choice in Castration-resistant Prostate Cancer

European Urology ◽

10.1016/j.eururo.2019.08.020 ◽

2020 ◽

Vol 77 (2) ◽

pp. 170-177 ◽

Cited By ~ 11

Author(s):

Ryon P. Graf ◽

Melanie Hullings ◽

Ethan S. Barnett ◽

Emily Carbone ◽

Ryan Dittamore ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Clinical Utility ◽

Treatment Choice ◽

The change in expression of prostate-specific membrane antigen in circulating tumor cells during treatments for castration-resistant prostate cancer

Annals of Oncology ◽

10.1093/annonc/mdy434.002 ◽

2018 ◽

Vol 29 ◽

pp. ix68

Author(s):

N. Nagaya ◽

M. Kanayama ◽

M. Nagata ◽

S. Horie

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Prostate Specific Membrane Antigen ◽

Castration Resistant ◽

Specific Membrane

Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer

Genes Chromosomes and Cancer ◽

10.1002/gcc.22824 ◽

2019 ◽

Vol 59 (4) ◽

pp. 225-239 ◽

Cited By ~ 4

Author(s):

Santosh Gupta ◽

Daniel H. Hovelson ◽

Gabor Kemeny ◽

Susan Halabi ◽

Wen‐Chi Foo ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Plasma Dna ◽

Genomic Alterations ◽

Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients

Prostate Cancer and Prostatic Diseases ◽

10.1038/s41391-018-0043-z ◽

2018 ◽

Vol 21 (3) ◽

pp. 411-418 ◽

Cited By ~ 12

Author(s):

Manish Kohli ◽

Jian Li ◽

Meijun Du ◽

David W Hillman ◽

Scott M. Dehm ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Plasma Cell ◽

Castration Resistant ◽

Free Dna ◽

Prognostic Association

Abstract 5588: Epithelial-to-mesenchymal markers of circulating tumor cells for detection of castration-resistant prostate cancer

10.1158/1538-7445.am2014-5588 ◽

2014 ◽

Author(s):

Chun-Liang Chen ◽

Pawel Osmulski ◽

Devalingam Mahalingam ◽

Aaron M. Horning ◽

Rohit R. Jadhav ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Abstract 375: Phenotypic and molecular characterization of circulating tumor cells (CTCs) in patients with castration resistant prostate cancer (CRPC) undergoing treatment with abiraterone acetate or enzalutamide

10.1158/1538-7445.am2015-375 ◽

2015 ◽

Author(s):

Jaymala Patel ◽

Vipul Bhargava ◽

Miaoling He ◽

Brad Foulk ◽

Denis A. Smirnov ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Molecular Characterization ◽

Circulating Tumor Cells ◽

Abiraterone Acetate ◽

Abstract 436: Prediction of aggressive disease in metastatic castration-resistant prostate cancer: The role of very small nuclear circulating tumor cells

10.1158/1538-7445.sabcs18-436 ◽

2019 ◽

Author(s):

Pin-Jung Chen ◽

Yu Jen Jan ◽

Pai-Chi Teng ◽

Jie-Fu Chen ◽

Shirley Cheng ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Aggressive Disease ◽